Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus

REFERENCES

1. 1.↵
   1. Manzi S,
   2. Meilahn EN,
   3. Rairie JE,
   4. Conte CG,
   5. Medsger TA Jr,
   6. Jansen-McWilliams L,
   7. et al.

   Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408–15.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Goldberg RJ,
   2. Urowitz MB,
   3. Ibañez D,
   4. Nikpour M,
   5. Gladman DD

   . Risk factors for development of coronary artery disease in women with systemic lupus erythematosus. J Rheumatol 2009;11:2454–61.

   OpenUrl
3. 3.↵
   1. Urowitz MB,
   2. Bookman AA,
   3. Koehler BE,
   4. Gordon DA,
   5. Smythe HA,
   6. Ogryzlo MA

   . The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221–5.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Nikpour M,
   2. Urowitz MB,
   3. Gladman DD

   . Premature atherosclerosis in systemic lupus erythematosus [review]. Rheum Dis Clin North Am 2005;31:329–54, vii–viii.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Esdaile JM,
   2. Abrahamowicz M,
   3. Grodzicky T,
   4. Li Y,
   5. Panaritis C,
   6. du Berger R,
   7. et al.

   Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331–7.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Bruce IN,
   2. Urowitz MB,
   3. Gladman DD,
   4. Hallett DC

   . Natural history of hypercholesterolemia in systemic lupus erythematosus. J Rheumatol 1999;26:2137–43.

   OpenUrlPubMed
7. 7.↵
   1. Asanuma Y,
   2. Oeser A,
   3. Shintani AK,
   4. Turner E,
   5. Olsen N,
   6. Fazio S,
   7. et al.

   Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2407–15.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Urowitz MB,
   2. Ibañez D,
   3. Gladman DD

   . Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 2007;34:70–5.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Urowitz MB,
   2. Gladman D,
   3. Ibañez D,
   4. Fortin P,
   5. Sanchez-Guerrero J,
   6. Bae S,
   7. et al;
   8. Systemic Lupus International Collaborating Clinics

   . Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum 2008;59:176–80.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Karp I,
    2. Abrahamowicz M,
    3. Fortin PR,
    4. Pilote L,
    5. Neville C,
    6. Pineau CA,
    7. et al.

    Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum 2008;59:169–75.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Nikpour M,
    2. Urowitz MB,
    3. Ibañez D,
    4. Harvey PJ,
    5. Gladman DD

    . Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study. Arthritis Res Ther 2011;13:R156.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Magder LS,
    2. Petri M

    . Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol 2012;176:708–19.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. D’Agostino RB Sr,
    2. Vasan RS,
    3. Pencina MJ,
    4. Wolf PA,
    5. Cobain M,
    6. Massaro JM,
    7. et al.

    General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743–53.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Ridker PM,
    2. Buring JE,
    3. Rifai N,
    4. Cook NR

    . Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007;297:611–9.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Gladman DD,
    2. Ibañez D,
    3. Urowitz MB

    . Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288–91.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Rubin DB

    . Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons; 1987.
17. 17.↵
    SAS Documentation. SAS version 9.3. 2011.
18. 18.↵
    1. Rubin DB

    . Inference and missing data. Biometrika 1976;63:581–92.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Rubin DB

    . Multiple imputation after 18+ years. J Am Stat Assoc 1996;91:473–89.

    OpenUrlCrossRef
20. 20.↵
    1. Barzi F,
    2. Woodward M

    . Imputations of missing values in practice: results from imputations of serum cholesterol in 28 cohort studies. Am J Epidemiology 2004;160:34–45.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Agresti A,
    2. Coull BA

    . Approximation is better than “exact” for interval estimation of binomial proportions. Am Stat 1998;52:119–26.

    OpenUrlCrossRef
22. 22.↵
    1. Kleinbaum DG,
    2. Klein M

    . Survival analysis: a self-learning text, third edition. New York: Springer; 2012:241–88.
23. 23.↵
    1. Grønnesby JK,
    2. Borgan O

    . A method for checking regression models in survival analysis based on the risk score. Lifetime Data Anal 1996;2:315–28.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Kawai VK,
    2. Solus JF,
    3. Oeser A,
    4. Rho YH,
    5. Raggi P,
    6. Bian A,
    7. et al.

    Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus. Lupus 2011;20:1526–34.

    OpenUrlAbstract/FREE Full Text